The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

Conclusion:
Following the availability of fingolimod, patients were more likely to discontinue injectable treatments. Those who switched to fingolimod were more likely to do so for convenience. Persistence was improved on fingolimod compared to other medications.

Source: Multiple Sclerosis - March 17, 2016 Category: Neurology Authors: Warrender-Sparkes, M., Spelman, T., Izquierdo, G., Trojano, M., Lugaresi, A., GrandMaison, F., Havrdova, E., Horakova, D., Boz, C., Oreja-Guevara, C., Alroughani, R., Iuliano, G., Duquette, P., Girard, M., Terzi, M., Hupperts, R., Grammond, P., Petersen, Tags: Original Research Papers Source Type: research